|
OTLK Outlook Therapeutics Inc 1649989 |
| Balance Sheet |
|
Current Assets
|
$23,168,201.00 |
|
Assets
|
$26,184,850.00 |
|
Current Liabilities
|
$28,679,051.00 |
|
Liabilities
|
$36,577,417.00 |
|
Equity
|
$-10,392,567.00 |
|
Shares Out
|
187096998.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-43,777,688.00 |
|
Investing Cash Flow
|
$-2,100,000.00 |
| Market Analysis |
Market Cap
|
$127,225,958.64 |
|
Price
|
$0.68 |
|
PB
|
0.46 |
|
EPS
|
-0.15 |
|
PS
|
90.01 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:45 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:36 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-17 |
-0.22 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-15 |
-0.16 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-14 |
-0.44 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view OTLK documents filed with the SEC.
OTLK Filings
Clear
